A new diagnostic code introduced by the Centers for Disease Control and Prevention (CDC) on October 1, 2025, has led to a significant increase in reported cases of cannabis hyperemesis syndrome (CHS). This surge is attributed to better identification and coding of the condition, rather than a genuine rise in its incidence. The CDC's new code has improved surveillance and estimation of CHS's public health impact, though the true number of affected individuals is likely still underestimated as emergency department data only capture severe cases. AI
RANK_REASON Policy change by a major health authority (CDC) leading to a measurable shift in reported statistics. [lever_c_demoted from significant: ic=1 ai=0.1]
- Cannabis hyperemesis syndrome
- Ginger Constantine
- PleoPharma
- United States Centers for Disease Control and Prevention
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
